Global Radiopharmaceuticals Market to Reach US$11.6 Billion by 2030, Driven by Rising Chronic Disease Prevalence and Diagnostic Advancements
A class of radioactive substances known as radiopharmaceuticals are utilised for either medicinal or diagnostic purposes. The areas of hyperintensity shown on positron emission tomography …
